In vitro analysis of liver steatosis using adverse outcome pathways: A case study with cyproconazole. (10th October 2018) - Luckert, C.; Braeuning, A.; de Sousa, G.; Durinck, S.; Katsanou, E.S.; Konstantinidou, P.; Machera, K.; Milani, E.S.; Peijnenburg, A.; Rahmani, R.; Rajkovic, A.; Spyropoulou, A.; et al.